Protagenic Takes Bold Step: 1-for-14 Reverse Split Aims to Preserve Nasdaq Listing - Stock Titan
2025-04-29 • Google News
Protagenic Therapeutics (PTIX)
US$ 3.0299-2.89%
Price Chart
Key Statistics
Market Cap
$ 3.09M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
59.33K
52W High
$ 15.54
52W Low
$ 2.35
Dividend Yield
0.00%
Beta
0.38
Technicals
50-Day MA
3.7891
200-Day MA
6.1543
52 Week High
15.5386
52 Week Low
2.35
About PTIX
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.
Employees
1
Headquarters
New York, NY
CEO
Dr. Garo H. Armen Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg